GALDY (Galderma Group AG) Other Current Receivables : $156 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Other Current Receivables?

Galderma Group AG's Other Current Receivables for the quarter that ended in Dec. 2024 was $156 Mil.

Galderma Group AG's quarterly Other Current Receivables declined from Dec. 2023 ($132.00 Mil) to Jun. 2024 ($54.00 Mil) but then increased from Jun. 2024 ($54.00 Mil) to Dec. 2024 ($156.00 Mil).

Galderma Group AG's annual Other Current Receivables increased from . 20 ($0.00 Mil) to Dec. 2023 ($132.00 Mil) and increased from Dec. 2023 ($132.00 Mil) to Dec. 2024 ($156.00 Mil).

Galderma Group AG Other Current Receivables Historical Data

The historical data trend for Galderma Group AG's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Other Current Receivables Chart

Galderma Group AG Annual Data

Trend

Dec23

Dec24

Other Current Receivables

132.00

156.00

Galderma Group AG Semi-Annual Data
	Jun23	Dec23	Jun24	Dec24
Other Current Receivables	-	132.00	54.00	156.00

Galderma Group AG Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Galderma Group AG Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (OTCPK:GALDY) » Definitions » Other Current Receivables

Traded in Other Exchanges

GDERF:USA GALDz:UK PY30:Germany GALD:Switzerland

Address

Zahlerweg 10, Zug, CHE, 6300

Website

https://www.galderma.com

Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.